Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical, histopathological, and molecular features of mucosa-associated lymphoid tissue (MALT) lymphoma carrying the t(X;14) (p11;q32)/GPR34-immunoglobulin heavy chain gene.

× No keyword cloud information.

2 in total

1. Burkitt leukemia with precursor B-cell features that developed after ruxolitinib treatment in a patient with hydroxyurea-refractory JAK2^V617F-myeloproliferative neoplasm.

Authors: Katsuhiro Fukutsuka; Futoshi Iioka; Fumiyo Maekawa; Miho Nakagawa; Chiyuki Kishimori; Masahiko Hayashida; Shunsuke Tagawa; Takashi Akasaka; Gen Honjo; Hitoshi Ohno
Journal: J Clin Exp Hematop Date: 2021-05-14

2. Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites.

Authors: Sarah Moody; Joe Sneath Thompson; Shih-Sung Chuang; Hongxiang Liu; Markus Raderer; George Vassiliou; Iwona Wlodarska; Fangtian Wu; Sergio Cogliatti; Alistair Robson; Margaret Ashton-Key; Yingwen Bi; John Goodlad; Ming-Qing Du
Journal: Haematologica Date: 2018-04-19 Impact factor: 9.941

2 in total

Clinical, histopathological, and molecular features of mucosa-associated lymphoid tissue (MALT) lymphoma carrying the t(X;14) (p11;q32)/GPR34-immunoglobulin heavy chain gene.

1. Burkitt leukemia with precursor B-cell features that developed after ruxolitinib treatment in a patient with hydroxyurea-refractory JAK2V617F-myeloproliferative neoplasm.

2. Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites.

1. Burkitt leukemia with precursor B-cell features that developed after ruxolitinib treatment in a patient with hydroxyurea-refractory JAK2^V617F-myeloproliferative neoplasm.